title: Zambian women's attitudes toward mass nevirapine therapy to prevent perinatal transmission of HIV.
abstract: Use of mass nevirapine therapy--universal provision of the drug without HIV testing--for prevention of perinatal HIV in high prevalence settings with extreme resource constraints is a controversial strategy. A quarter of pregnant Zambian women surveyed would prefer to receive nevirapine through a non-testing mass strategy, and most would support mass therapy as a policy if it would make the drug available to a larger proportion of the at-risk population.
authors.forename: M
authors.initials: M
authors.lastname: Sinkala
authors.forename: J P
authors.initials: JP
authors.lastname: Stout
authors.forename: S H
authors.initials: SH
authors.lastname: Vermund
authors.forename: R L
authors.initials: RL
authors.lastname: Goldenberg
authors.forename: J S
authors.initials: JS
authors.lastname: Stringer
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use*; D001294:Attitude to Health; D005260:Female; D015658:HIV Infections / Q000175:diagnosis / Q000517:prevention & control* / Q000635:transmission; D006801:Humans; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D019829:Nevirapine / Q000627:therapeutic use*; D011247:Pregnancy; D011795:Surveys and Questionnaires; D015024:Zambia
chemical_list: D019380:Anti-HIV Agents; D019829:Nevirapine